137 related articles for article (PubMed ID: 34492630)
1. The role of oxidative stress and haematological parameters in relapsing-remitting multiple sclerosis in Kurdish population.
Rasoul AA; Khudhur ZO; Hamad MS; Ismaeal YS; Smail SW; Rasul MF; Mohammad KA; Bapir AA; Omar SA; Qadir MK; Rajab MF; Salihi A; Kaleem M; Rizwan MA; Qureshi AS; Iqbal ZM; Qudratullah
Mult Scler Relat Disord; 2021 Nov; 56():103228. PubMed ID: 34492630
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis.
Ortiz GG; Macías-Islas MA; Pacheco-Moisés FP; Cruz-Ramos JA; Sustersik S; Barba EA; Aguayo A
Dis Markers; 2009; 26(1):35-9. PubMed ID: 19242067
[TBL] [Abstract][Full Text] [Related]
3. Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics.
Ghonimi NAM; Elsharkawi KA; Khyal DSM; Abdelghani AA
Mult Scler Relat Disord; 2021 Jun; 51():102941. PubMed ID: 33895606
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
Wang P; Xie K; Wang C; Bi J
Eur Neurol; 2014; 72(3-4):249-54. PubMed ID: 25277682
[TBL] [Abstract][Full Text] [Related]
5. Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation.
Ljubisavljevic S; Stojanovic I; Cvetkovic T; Vojinovic S; Stojanov D; Stojanovic D; Stefanovic N; Pavlovic D
J Neurol Sci; 2014 Feb; 337(1-2):8-13. PubMed ID: 24269090
[TBL] [Abstract][Full Text] [Related]
6. Correlation of lipid peroxidation and nitric oxide metabolites, trace elements, and antioxidant enzymes in patients with sickle cell disease.
Antwi-Boasiako C; Dankwah GB; Aryee R; Hayfron-Benjamin C; Aboagye G; Campbell AD
J Clin Lab Anal; 2020 Jul; 34(7):e23294. PubMed ID: 32170816
[TBL] [Abstract][Full Text] [Related]
7. Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
Oliveira SR; Kallaur AP; Reiche EMV; Kaimen-Maciel DR; Panis C; Lozovoy MAB; Morimoto HK; Maes M; Dichi I; Simão ANC
Mol Neurobiol; 2017 May; 54(4):2961-2968. PubMed ID: 27026183
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients.
Juybari KB; Ebrahimi G; Momeni Moghaddam MA; Asadikaram G; Torkzadeh-Mahani M; Akbari M; Mirzamohammadi S; Karimi A; Nematollahi MH
Mult Scler Relat Disord; 2018 Jan; 19():79-84. PubMed ID: 29156301
[TBL] [Abstract][Full Text] [Related]
9. Plasma thiol/disulphide homeostasis changes in patients with relapsing-remitting multiple sclerosis.
Ozben S; Kucuksayan E; Koseoglu M; Erel O; Neselioglu S; Ozben T
Int J Clin Pract; 2021 Jul; 75(7):e14241. PubMed ID: 33891773
[TBL] [Abstract][Full Text] [Related]
10. Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients.
Naseri A; Forghani N; Sadigh-Eteghad S; Shanehbandi D; Asadi M; Nasiri E; Talebi M
Mult Scler Relat Disord; 2022 Jan; 57():103432. PubMed ID: 34922253
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
Acar A; Ugur Cevik M; Evliyaoglu O; Uzar E; Tamam Y; Arıkanoglu A; Yucel Y; Varol S; Onder H; Taşdemir N
Acta Neurol Belg; 2012 Sep; 112(3):275-80. PubMed ID: 22450709
[TBL] [Abstract][Full Text] [Related]
12. Changes in levels of oxidative stress markers and some neuronal enzyme activities in cerebrospinal fluid of multiple sclerosis patients.
Bartova R; Petrlenicova D; Oresanska K; Prochazkova L; Liska B; Turecky L; Durfinova M
Neuro Endocrinol Lett; 2016; 37(2):102-6. PubMed ID: 27179571
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis.
Polachini CR; Spanevello RM; Zanini D; Baldissarelli J; Pereira LB; Schetinger MR; da Cruz IB; Assmann CE; Bagatini MD; Morsch VM
Neurotox Res; 2016 Feb; 29(2):230-42. PubMed ID: 26690779
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis.
Sanoobar M; Eghtesadi S; Azimi A; Khalili M; Jazayeri S; Reza Gohari M
Int J Neurosci; 2013 Nov; 123(11):776-82. PubMed ID: 23659338
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis.
Sánchez-López AL; Ortiz GG; Pacheco-Moises FP; Mireles-Ramírez MA; Bitzer-Quintero OK; Delgado-Lara DLC; Ramírez-Jirano LJ; Velázquez-Brizuela IE
Arch Med Res; 2018 Aug; 49(6):391-398. PubMed ID: 30595364
[TBL] [Abstract][Full Text] [Related]
16. Why do multiple sclerosis and migraine coexist?
Hamamcı M; Göcmen AY; Say B; Alpua M; Badem ND; Ergün U; Ertuğrul İnan L
Mult Scler Relat Disord; 2020 May; 40():101946. PubMed ID: 31982663
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
Ohlmeier C; Gothe H; Haas J; Osowski U; Weinhold C; Blauwitz S; Schmedt N; Galetzka W; Berkemeier F; Tackenberg B; Stangel M
PLoS One; 2020; 15(5):e0231846. PubMed ID: 32357176
[TBL] [Abstract][Full Text] [Related]
18. In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.
Choi IY; Lee P; Adany P; Hughes AJ; Belliston S; Denney DR; Lynch SG
Mult Scler; 2018 Jul; 24(8):1029-1038. PubMed ID: 28569645
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Relationship between Antioxidant Enzymes, Oxidative Stress Markers, and Clinical Profile in Relapsing-Remitting Multiple Sclerosis.
Bizoń A; Chojdak-Łukasiewicz J; Budrewicz S; Pokryszko-Dragan A; Piwowar A
Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627633
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.
Foo EC; Russell M; Lily O; Ford HL
Mult Scler Relat Disord; 2020 Sep; 44():102330. PubMed ID: 32599468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
